DNAVSONCO• 12 Months (Normalized)
DNA vs ONCO (Ginkgo Bioworks Holdings Inc. vs Onconetix Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
ONCO Performance $0.74
-99.53%
Onconetix Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+99.53 pts
DNA outperforming by 99.53 percentage points
DNAONCO
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA ONCO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | DNA Price | DNA Gain (%) | ONCO Price | ONCO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $- | $0.74 | -99.53% | - | |
| Oct 01, 2026 | $- | $0.74 | -99.53% | - | |
| Sep 30, 2026 | $- | $0.78 | -99.50% | - | |
| Sep 29, 2026 | $- | $0.82 | -99.48% | - | |
| Sep 28, 2026 | $10.46 | -34.50% | $1.11 | -99.30% | +64.80% |
| Sep 25, 2026 | $10.66 | -33.25% | $- | - | |
| Sep 24, 2026 | $10.25 | -35.82% | $- | - | |
| Sep 23, 2026 | $8.58 | -46.27% | $0.91 | -99.42% | +53.15% |
| Sep 22, 2026 | $9.37 | -41.33% | $0.68 | -99.57% | +58.24% |
| Sep 21, 2026 | $7.98 | -50.03% | $0.66 | -99.58% | +49.55% |
| Sep 18, 2026 | $7.88 | -50.66% | $0.64 | -99.59% | +48.93% |
| Sep 17, 2026 | $7.84 | -50.91% | $0.66 | -99.58% | +48.67% |
| Sep 16, 2026 | $7.06 | -55.79% | $0.66 | -99.58% | +43.79% |
| Sep 15, 2026 | $6.99 | -56.23% | $0.65 | -99.59% | +43.36% |
| Sep 14, 2026 | $7.01 | -56.11% | $0.64 | -99.60% | +43.49% |
Page 1 of 17